FORE Support Services has announced the launch of its AuthPal automated prior authorization technology. The announcement was made at the Radiology Business Management Association (RBMA) 2015 Radiology Summit Conference.

Professional physician associations consider certain routine tests before elective surgery to be of low value and high cost, and have sought to discourage their utilization. Nonetheless, a new national study by researchers at NYU Langone Medical Center finds that despite these peer-reviewed recommendations, no significant changes have occurred over a 14-year period in the rates of several kinds of these pre-operative tests.

Healthcare networks can now remotely manage computed tomography (CT) protocols and capture valuable analytics that could improve safety with Toshiba America Medical Systems Inc.'s CT Vitality software. Part of the Vitality Solutions portfolio, CT Vitality is available on Aquilion ONE systems and will facilitate protocol utilization and dose usage analytics so hospitals and multi-site integrated delivery networks (IDNs) can ensure consistently safe scans every time.

Konica Minolta announced new Blue Moon Lifecycle Solutions designed to help customers minimize downtime, maximize productivity and eliminate risk throughout the lifetime of their AeroDR systems. The new solutions help customers achieve economic value, clinical confidence and worry-free operation with AeroDR.

Blue Moon Lifecycle Solutions

Navidea Biopharmaceuticals announced that results from an investigator-initiated, comparative study of Lymphoseek (technetium Tc-99m tilmanocept) injection versus filtered Tc-99m Sulfur Colloid (fTcSC) were presented at the 2015 Society of Nuclear Medicine and Molecular Imaging (SNMMI) conference. The study measured injection site pain in patients with breast cancer undergoing lymphoscintigraphy. Results of the randomized, double-blinded trial — led by Anne Wallace, M.D., professor of surgery at University of California, San Diego School of Medicine — highlighted that fTcSC caused statistically significant greater levels of pain after injection compared to Lymphoseek.

Piramal Imaging announced the presentation of additional analyses from its florbetaben phase 3 histopathology study, in which the florbetaben positron emission tomography (PET) signal from binding to morphologically distinct beta-amyloid plaques was examined. The analyses also examined the potential influence of plaques in the reference region for quantification. The results, which were presented at the 2015 annual meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI) in Baltimore, provide additional details on the topographic distribution of different beta-amyloid aggregates in the brain and on quantification.

GE Healthcare announced that it has created a solution to make positron emission tomography (PET) tracers for diagnostic imaging more readily available. At the Society for Nuclear Medicine and Molecular Imaging (SNMMI), GE launched new products for radiopharmaceutical manufacturing, including GENtrace, a small cyclotron, with a smaller footprint that is optimized for ease-of-use; and FASTlab 2, a PET tracer production module with FDG Duo cassettes, to maximize the hot cell capacity.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now